How to Launch a GLP-1 Program at Your Med Spa

GLP-1 is the highest-demand, highest-scrutiny program a med spa can launch. demand is not your problem — patients are already asking, and they are already buying somewhere. your problems are clinical structure, sourcing, payment processing, and advertising a weight program on platforms that are specifically sensitive about weight. get those four right and this becomes the largest revenue line in the clinic.

before anything: the questions your attorney answers

this category attracts more regulatory attention than anything else on a med spa menu, and the rules have moved repeatedly. do not build on assumptions or on what the clinic across town appears to be doing.

• —who prescribes, under what licensure, and in which states
• —does your state require a synchronous visit before an initial prescription
• —what is your sourcing pathway, and is it currently permissible for the specific product involved — this has changed more than once and requires current guidance
• —how does corporate practice of medicine affect ownership and billing in your state
• —what claims can you make in advertising, and what does your board consider misleading
• —what documentation, monitoring and follow-up does your protocol require

to be direct: nothing here is legal or medical advice, and this category in particular is not one to improvise in. get written guidance from a healthcare attorney and confirm with your state medical board before you take a single patient.

design the program, not the prescription

the clinics that struggle sell a drug. the clinics that thrive sell a supervised weight program in which medication is one component. that distinction is clinical best practice, it is what regulators and platforms want to see, and it converts better because patients are buying a solution rather than a vial.

a complete program includes:

1. 1.a real intake and clinical evaluation, including labs where your protocols require them
2. 2.titration protocol with defined checkpoints and dose escalation criteria
3. 3.scheduled provider check-ins, not just a monthly shipment
4. 4.nutrition and protein guidance, plus resistance-training guidance for muscle preservation
5. 5.side-effect management with a clear path to reach a human quickly
6. 6.a defined maintenance and off-ramp plan — patients ask about this constantly and clinics rarely have an answer
7. 7.body composition tracking rather than scale weight alone

that last pair — muscle preservation and the off-ramp — are the strongest differentiators available right now. every competitor sells the medication. very few have a credible answer for what happens at month nine, and patients notice.

pricing the program

GLP-1 pricing varies widely by market and by product cost, which itself moves. the structural decisions matter more than the specific number.

• —price monthly and all-in. hidden lab fees, consult fees and titration surcharges generate refunds and complaints.
• —do not tier by dose. patients whose dose escalates should not feel penalized for following the protocol — dose-based pricing creates a perverse incentive and constant billing friction.
• —include the provider support in the price and say so prominently. it is your differentiation against cheaper sellers.
• —offer a quarterly prepay at a modest discount. it improves cash flow and materially extends average patient life.
• —price a maintenance phase, and market it. maintenance patients are your highest-margin, lowest-effort cohort.

you will lose some price shoppers to whoever is cheapest online this month. that is fine. those patients churn fastest, complain most, and produce the chargebacks that endanger merchant accounts. compete on oversight and outcomes.

marketing a GLP-1 program without getting shut down

weight-related advertising is among the most tightly reviewed categories on every major platform, and for good reason. the constraint is simple: do not imply personal health attributes, do not use dramatic body-transformation hooks, do not promise specific outcomes, and do not target based on assumed weight status.

what works instead is more effective anyway, because it selects for patients who want supervision rather than the cheapest vial:

• —provider-to-camera explaining who the program is for and who they turn away — high trust, low review risk
• —process transparency: what the intake covers, what the check-ins look like, what arrives at the door
• —objection-handling creative: cost, safety, muscle loss, 'what happens when I stop', 'is this legitimate'
• —patient stories anchored in daily-life change — energy, clothes, sleep, joints — rather than scale numbers and side-by-side photos
• —local proof: your clinic, your provider, your city
• —comparison against the cheap online option, framed on oversight and support rather than disparagement

and volume. LIVV Well ran 294 live ads to find winners at 6.79-14.96 ROAS. on AC-NEXTGEN, one ad returned $53,269 on $6,049 in spend. those outcomes come from testing many angles, not from perfecting four.

operations: what breaks at scale

a GLP-1 program at 30 patients is easy. at 300, the failure points are predictable.

1. 1.provider capacity for check-ins and titration decisions. build protocol-driven workflows and support staff early, or your provider becomes the bottleneck.
2. 2.side-effect volume. a meaningful percentage of patients will have GI symptoms. define a triage path and a response-time standard before you need one.
3. 3.cold-chain logistics. temperature-sensitive product plus summer shipping equals replacement orders you did not budget for.
4. 4.payment failures at volume. dunning that recovers involuntary churn is worth real money at 300 patients.
5. 5.supply variability. sourcing in this category has been unstable; have contingency and communicate proactively with patients when timelines slip.
6. 6.support response time, which quietly determines your chargeback rate and therefore your merchant account's survival.

retention is the whole business

GLP-1 patients churn for specific, predictable reasons: side effects in the first month, a plateau around month three or four, cost fatigue, and reaching a goal with no maintenance plan offered. each has a countermeasure.

• —warn honestly about side effects before they occur, and make a human reachable in the first two weeks
• —prepare patients for the plateau in advance so it reads as expected rather than as failure
• —track and celebrate non-scale outcomes so progress does not depend on one number
• —offer a maintenance program before they hit goal, not after they cancel
• —attach in-clinic services — skin, body contouring, injectables — which both improve results and deepen the relationship

anyone can ship the medication. the med spa that owns the check-in, the plateau conversation, and the maintenance plan owns the patient.

a realistic launch timeline

1. 1.weeks 1-2: attorney review, provider protocols, sourcing relationship, intake design
2. 2.weeks 2-3: high-risk merchant account, program page, intake build, email and SMS flows, 3PL connection
3. 3.week 4: soft launch to your existing patient database only. work the operational kinks out on patients who already trust you.
4. 4.weeks 5-8: paid acquisition at a controlled budget with 20-40 creatives in market
5. 5.weeks 9-12: scale winners, and shift your primary metric from cost per intake to month-two retention

the marketing infrastructure is the fast part — that build runs under two weeks. the regulatory and clinical foundation is what sets your actual date, and it is the part you should not compress.